4/A: Casdin Partners Amends Ownership Disclosure for Standard BioTools Inc. (LAB)
Ownership Disclosure (Form 4/A)
Casdin Partners files an amended Form 4 to update beneficial ownership information in Standard BioTools Inc. (LAB), indicating continued director and 10% ownership status.
Summary
- Casdin Partners Master Fund, L.P., along with related entities and individuals, filed an amended Form 4 with the SEC regarding their beneficial ownership in Standard BioTools Inc. (LAB).
- The amendment updates the beneficial ownership information previously reported.
- As of the latest filing, the reporting persons collectively own 2,748,255 shares of Common Stock, including Restricted Stock Units (RSUs).
- Eli Casdin is a director of Standard BioTools and represents the Reporting Persons on the board.
- The filing indicates that Casdin entities may be deemed directors by deputization and disclaim beneficial ownership except to the extent of their pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard ownership disclosure. There are no explicit positive or negative indicators, but the continued ownership suggests confidence.
Positives
- The filing indicates continued significant ownership by Casdin Partners in Standard BioTools Inc.
- Eli Casdin's continued role as a director representing Casdin entities suggests ongoing involvement and oversight.
Management Comments
- Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer.
- Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Industry Context
This filing is a routine disclosure related to insider ownership and is common for publicly traded companies. It provides transparency regarding the holdings of significant shareholders and directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the ownership structure of the company.
- It assures stakeholders that significant shareholders remain invested in the company.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date of Earliest Transaction |
| 08/06/2024 | Date of Original Filed |
| 07/23/2024 | 25% of certain RSUs vested |
| 06/28/2025 | Certain RSUs vest in full on the earlier to occur of this date and one day prior to the date of the Company's next annual meeting of stockholders |
| 03/04/2025 | Date of signatures on the Form 4/A |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.